World wide shipping
Medicines from all over the world. We will help you find any drug in 24 hours. Prices for medicines are presented for informational purposes only.

Besponsa (Inotuzumab ozogamicin ) 0.9 mg Pfizer

In Stock
0 $
5 000 $
+
Description

Indications

Inotuzumab ozogamicin is indicated as monotherapy for the treatment of adult patients with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL), including adult patients with Philadelphia chromosome-positive (Ph+) B-cell precursor ALL after failure of therapy with at least one tyrosine kinase inhibitor (TKI).

Features
  • Commercial name:
    Беспонза
  • Сhemical name:
    инотузумаб озогамицин
  • Dosage:
    1 mg
  • Quantity:
    one
  • Release form:
    Леофілізат
  • Виробник:
    Pfizer
Reviews
No reviews yet
Write Review
Name*
Email
Write a Review*